Osteoporosis, Postmenopausal
"Osteoporosis, Postmenopausal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Descriptor ID |
D015663
|
| MeSH Number(s) |
C05.116.198.579.610 C18.452.104.579.610
|
| Concept/Terms |
Osteoporosis, Postmenopausal- Osteoporosis, Postmenopausal
- Perimenopausal Bone Loss
- Bone Loss, Postmenopausal
- Bone Losses, Postmenopausal
- Postmenopausal Bone Losses
- Osteoporosis, Post-Menopausal
- Osteoporoses, Post-Menopausal
- Osteoporosis, Post Menopausal
- Post-Menopausal Osteoporoses
- Post-Menopausal Osteoporosis
- Postmenopausal Osteoporosis
- Osteoporoses, Postmenopausal
- Postmenopausal Osteoporoses
- Bone Loss, Perimenopausal
- Bone Losses, Perimenopausal
- Perimenopausal Bone Losses
- Postmenopausal Bone Loss
|
Below are MeSH descriptors whose meaning is more general than "Osteoporosis, Postmenopausal".
Below are MeSH descriptors whose meaning is more specific than "Osteoporosis, Postmenopausal".
This graph shows the total number of publications written about "Osteoporosis, Postmenopausal" by people in this website by year, and whether "Osteoporosis, Postmenopausal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 0 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteoporosis, Postmenopausal" by people in Profiles.
-
Qaseem A, Forciea MA, McLean RM, Denberg TD. Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017 Jun 06; 166(11):818-839.
-
Watts NB, Cauley JA, Jackson RD, LaCroix AZ, Lewis CE, Manson JE, Neuner JM, Phillips LS, Stefanick ML, Wactawski-Wende J, Crandall C. No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative. J Clin Endocrinol Metab. 2017 Jan 01; 102(1):302-308.
-
Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative. Semin Reprod Med. 2014 Nov; 32(6):454-62.
-
Jackson RD, Wright NC, Beck TJ, Sherrill D, Cauley JA, Lewis CE, LaCroix AZ, LeBoff MS, Going S, Bassford T, Chen Z. Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative. Calcif Tissue Int. 2011 Mar; 88(3):198-208.
-
Orchard TS, Cauley JA, Frank GC, Neuhouser ML, Robinson JG, Snetselaar L, Tylavsky F, Wactawski-Wende J, Young AM, Lu B, Jackson RD. Fatty acid consumption and risk of fracture in the Women's Health Initiative. Am J Clin Nutr. 2010 Dec; 92(6):1452-60.
-
Derman R, Kohles JD, Babbitt A. Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment. Clin Interv Aging. 2009; 4:357-65.
-
Foster SA, Foley KA, Meadows ES, Johnston JA, Wang S, Pohl GM, Long SR. Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates. BMC Womens Health. 2008; 8:24.
-
LaCroix AZ, Lee JS, Wu L, Cauley JA, Shlipak MG, Ott SM, Robbins J, Curb JD, Leboff M, Bauer DC, Jackson RD, Kooperberg CL, Cummings SR. Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc. 2008 Aug; 56(8):1434-41.
-
Jackson RD, Shidham S. The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative. Curr Osteoporos Rep. 2007 Dec; 5(4):153-9.
-
Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA. 2007 Nov 28; 298(20):2389-98.